Editas Medicine Inc (0IFK)
LSE
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 6.05M | 13.73M | 31.94M | 20.53M | 90.73M | 25.54M | 19.71M | 78.12M |
営業利益 | -97.19M | -119.93M | -113.73M | -140.92M | -134.84M | -193.15M | -225.95M | -169.18M |
税引前収入 | -97.18M | -120.32M | -109.95M | -133.75M | -115.98M | -192.5M | -220.43M | -153.22M |
純利益 | -97.23M | -120.32M | -109.95M | -133.75M | -115.98M | -192.5M | -220.43M | -153.22M |
優先配当 | -47k | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -2.715 | -2.703 | -2.255 | -2.461 | -1.854 | -2.815 | -3.206 | -1.876 |
EBIT | -97.25M | -119.35M | -113.4M | -141.06M | -118.58M | -194.84M | -224.66M | -170.79M |
EBITDA | -95.99M | -117.25M | -110.47M | -138.09M | -130.88M | -188.09M | -219.61M | -163.12M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約